The effects of tarantula cubensis extract on renal ischemia reperfusion injury in rats.
Renal ischemia-reperfusion injury
Tarantula cubensis extract
inflammation
oxidative stress
Journal
Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
18
10
2021
accepted:
09
10
2023
medline:
24
7
2023
pubmed:
21
7
2023
entrez:
21
7
2023
Statut:
ppublish
Résumé
Renal ischemia-reperfusion (IR) related acute kidney injury (AKI) is an important health problem and has not yet been fully treated. Tarantula cubensis extract (TCE) is a homeopathic drug that has antiinflammatory and antioxidant effects. This study aimed to investigate the effects of TCE on renal ischemia-reperfusion injury in rats. This study was carried out on 48 Spraque-Dawley male rats, which were divided into six groups. The first, second, and third groups were control, sham, and IR groups, respectively. Group four received IR and 0.2 mL of 96% ethanol. Group five and six received ischemia and reperfusion and TCE 0.01 and 0.1 mg per rat (which correspond to approximately 0.04 mg/kg, and 0.4 mg/kg), respectively. Tumor necrosis factor alpha (TNF-α), interleukin-1beta (IL-1β), total antioxidant status (TAS), and total oxidant status (TOS) levels in renal tissue were measured by enzyme-linked immunosorbent assay (ELISA). Oxidative stress index (OSI) was obtained by proportioning TAS and TOS. Superoxide dismutase (SOD), myeloperoxidase (MPO) activities, and malondialdehyde (MDA) levels were determined by manual spectrophotometric methods. The histopathological changes were evaluated via hematoxylineosin and immunohistochemical staining. In IR group, renal tissue TNF-α and IL-1β levels were significantly higher than control group (p < 0.0001 for both), and low(p < 0.0001 for both) and high dose (p < 0.0001 for both) TCE administration decreased these markers. Low and high doses of TCE decreased OSI values compared with IR group (p = 0.04 and p = 0.001 respectively). Although TCE decreased MDA levels, it was not statistically significant. MPO levels significantly decreased. In addition, TCE has been found to prevent hemorrhage, cast formation, and dilatation caused by IR in renal tissues stained with hematoxylin-eosin. And also, the most intense nuclear factor kappa B (NFκB) and caspase-3 immunopositivity found in IR group was decreased in both of the TCE groups. Although TCE showed a protective effect by inhibiting inflammation against IR damage in renal tissues, there was no clear effect on oxidative stress. Larger and more detailed studies are needed to clarify the issue.
Sections du résumé
BACKGROUND
BACKGROUND
Renal ischemia-reperfusion (IR) related acute kidney injury (AKI) is an important health problem and has not yet been fully treated. Tarantula cubensis extract (TCE) is a homeopathic drug that has antiinflammatory and antioxidant effects. This study aimed to investigate the effects of TCE on renal ischemia-reperfusion injury in rats.
METHODS
METHODS
This study was carried out on 48 Spraque-Dawley male rats, which were divided into six groups. The first, second, and third groups were control, sham, and IR groups, respectively. Group four received IR and 0.2 mL of 96% ethanol. Group five and six received ischemia and reperfusion and TCE 0.01 and 0.1 mg per rat (which correspond to approximately 0.04 mg/kg, and 0.4 mg/kg), respectively. Tumor necrosis factor alpha (TNF-α), interleukin-1beta (IL-1β), total antioxidant status (TAS), and total oxidant status (TOS) levels in renal tissue were measured by enzyme-linked immunosorbent assay (ELISA). Oxidative stress index (OSI) was obtained by proportioning TAS and TOS. Superoxide dismutase (SOD), myeloperoxidase (MPO) activities, and malondialdehyde (MDA) levels were determined by manual spectrophotometric methods. The histopathological changes were evaluated via hematoxylineosin and immunohistochemical staining.
RESULTS
RESULTS
In IR group, renal tissue TNF-α and IL-1β levels were significantly higher than control group (p < 0.0001 for both), and low(p < 0.0001 for both) and high dose (p < 0.0001 for both) TCE administration decreased these markers. Low and high doses of TCE decreased OSI values compared with IR group (p = 0.04 and p = 0.001 respectively). Although TCE decreased MDA levels, it was not statistically significant. MPO levels significantly decreased. In addition, TCE has been found to prevent hemorrhage, cast formation, and dilatation caused by IR in renal tissues stained with hematoxylin-eosin. And also, the most intense nuclear factor kappa B (NFκB) and caspase-3 immunopositivity found in IR group was decreased in both of the TCE groups.
DISCUSSION
CONCLUSIONS
Although TCE showed a protective effect by inhibiting inflammation against IR damage in renal tissues, there was no clear effect on oxidative stress. Larger and more detailed studies are needed to clarify the issue.
Identifiants
pubmed: 37476882
doi: 10.55730/1300-0144.5606
pmc: PMC10387895
doi:
Substances chimiques
Tumor Necrosis Factor-alpha
0
Antioxidants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
463-474Références
Homeopathy. 2002 Jul;91(3):166-70
pubmed: 12322871
Contrib Nephrol. 2001;(132):7-21
pubmed: 11395913
J Vis Exp. 2013 Aug 09;(78):
pubmed: 23963468
Exp Ther Med. 2016 Oct;12(4):2009-2014
pubmed: 27698686
J Urol. 2008 Jul;180(1):19-30
pubmed: 18485395
Turk Neurosurg. 2019;29(5):743-749
pubmed: 31353438
Clin Biochem. 2004 Apr;37(4):277-85
pubmed: 15003729
Vet Pathol. 2016 Jan;53(1):87-101
pubmed: 26319781
Methods Mol Biol. 1995;42:1-218
pubmed: 7655571
J Urol. 2013 Sep;190(3):1110-5
pubmed: 23517744
Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):206-10
pubmed: 23827690
J Cell Physiol. 2019 Apr;234(4):4572-4581
pubmed: 30191993
J Urol. 2007 Jun;177(6):2371-4
pubmed: 17509361
J Renal Inj Prev. 2015 Jun 01;4(2):20-7
pubmed: 26060833
Anticancer Agents Med Chem. 2022;22(10):1962-1969
pubmed: 34477527
Homeopathy. 2015 Jul;104(3):205-10
pubmed: 26143454
Ren Fail. 2018 Nov;40(1):680-686
pubmed: 30741618
Homeopathy. 2012 Jul;101(3):159-64
pubmed: 22818233
J Vet Sci. 2015;16(2):213-9
pubmed: 25549212
Transplant Proc. 2001 Nov-Dec;33(7-8):3741-2
pubmed: 11750594
Clin Biochem. 2005 Dec;38(12):1103-11
pubmed: 16214125
Br J Pharmacol. 2012 Jul;166(6):1905-15
pubmed: 22324445
J Wound Care. 2017 Feb 2;26(2):66-71
pubmed: 28182522
Life Sci. 2020 Sep 1;256:117860
pubmed: 32534037
Cells Tissues Organs. 2012;196(5):442-55
pubmed: 22722667
Vet Rec. 2007 Apr 7;160(14):486-8
pubmed: 17416727